Ambar Protein Industries ‘s Q1 Report: Revenue Falls by 0.18% YoY

The comprehensive analytics outlining the performance and outlook of Ambar Protein Industries Limited‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at Ambar Protein Industries Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -0.18 %. However, it did see a marginal increase of 3.95 % from the previous quarter. Expenses decreased slightly by -0.18 % quarter-on-quarter, aligning with the annual decline of -0.57 %. Operating profit, while up 13.08 % compared to last year, faced a quarter-on-quarter increase of 486.84 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 0.37 %, but an expansion of 4.01 % sequentially. Other income fell by -28.99 % compared to the last quarter, despite an annual growth of 86.32 %. Interest expenses surged remarkably by 12 % from the previous quarter, yet the year-over-year decrease remains at a moderate -12.5 %. Depreciation costs fell by -5.88 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -3.03 %. Profit before tax grew annually by 30.29 % but saw an increase from the preceding quarter by 276.74 %.
Tax expenses as a percentage of profits decreased slightly by -3.02 % compared to last year, with a more notable quarter-on-quarter increase of 89.16 %. Net profit rose by 36.51 % year-on-year but experienced a 482.22 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 35.75 % but a quarterly rise of 470.37 %. In summary, Ambar Protein Industries Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing Ambar Protein Industries Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -0.18 % year-on-year, however, there was a minor increase of 3.95 % from the previous quarter. Expenses decreased by -0.57 % compared to the previous year, with a decrease of -0.18 % quarter-on-quarter. Operating Profit surged by 13.08 % annually, and saw a 486.84 % increase from the last quarter.
Net Profit showed yearly increase of 36.51 %, and experienced a 482.22 % increase from the previous quarter. Earnings Per Share (EPS) rose by 35.75 % annually, however rose by 470.37 % compared to the last quarter. In essence, while Ambar Protein Industries Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.